Chapter 21. Primary Pancreatic Adenocarcinoma

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor12,13,14,15,16,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology17,18,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology16,19,20 and
  4. Yuman Fong MD Professor of Surgery21,22
  1. Christopher L. Wolfgang MD, PhD, FACS1,
  2. Timothy M. Pawlik MD, MPH, FACS2,
  3. Ralph H. Hruban MD3,
  4. Karen M. Horton MD4,
  5. Elliot K. Fishman MD5,
  6. Robert A. Meguid MD6,
  7. Daniel Laheru MD7,
  8. Joseph Herman MD, MSc8,
  9. Manuel Hildago MD, PhD9,
  10. Jeffrey Infante MD10 and
  11. Wells Messersmith MD11

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch21

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

Wolfgang, C. L., Pawlik, T. M., Hruban, R. H., Horton, K. M., Fishman, E. K., Meguid, R. A., Laheru, D., Herman, J., Hildago, M., Infante, J. and Messersmith, W. (2008) Primary Pancreatic Adenocarcinoma, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch21

Editor Information

  1. 12

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 13

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 14

    Cancer Research, UK

  4. 15

    Queen Mary University of London, UK

  5. 16

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 17

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 18

    Southern Arizona VA Health Care System, USA

  8. 19

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 20

    University of Oxford, UK

  10. 21

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 22

    Weill Cornell Medical Center, New York, USA

Author Information

  1. 1

    Johns Hopkins Hospital, Baltimore, MD, USA

  2. 2

    Division of Surgical Oncology, Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA

  3. 3

    The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA

  4. 4

    Johns Hopkins Medical Institutions, Baltimore, MD, USA

  5. 5

    Johns Hopkins Hospital, Department of Radiology, Baltimore, MD, USA

  6. 6

    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

  7. 7

    Department of Medical Oncology, The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

  8. 8

    Department of Radiation Oncology, Sidney Kimmel Cancer Center, The Johns Hopkins University, Baltimore, MD, USA

  9. 9

    The Johns Hopkins University School of Medicine, Baltimore, MD, USA

  10. 10

    Sarah Cannon Research Institute, Nashville, TN, USA

  11. 11

    Division of Medical Oncology, Department of Medicine, University of Colorado, Aurora, CO, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • primary pancreatic adenocarcinoma;
  • infiltrating ductal adenocarcinoma;
  • serous cystic neoplasms;
  • solid pseudopapillary neoplasms;
  • CT technology and multidetector CT scanners (MDCT);
  • CT in detection and staging for pancreatic adenocarcinoma patients;
  • preoperative biliary decompression;
  • pancreaticoduodenectomy (Whipple operation);
  • pancreatic cancer - neoadjuvant therapy;
  • pancreatic neoplasms - adenocarcinomas and prognosis grim

Summary

This chapter contains sections titled:

  • Diagnosis

  • Treatment

  • Prognosis and follow-up

  • References